Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations
Statutory instrument
laid in the House of Lords
and
House of Commons, on Wednesday, 2 September 2020 by Secretary Elizabeth Truss on behalf of the Department for International Trade.
It was approved by the House of Commons on Tuesday, 29 September 2020.
It was made on Wednesday, 25 November 2020.
About this statutory instrument
Reference
SI 2020/1354 2020/Session
2019-21Coming into force
In accordance with regulation 1Procedure
AffirmativeLaying authority
ActLaid in draft
YesReferred to
DLRelated items
Exiting The European Union (International Trade)
Tuesday, 29 September 2020
Parliamentary proceedings
House of Commons
Tuesday, 29 September 2020
Parliamentary proceedings
House of Commons
Draft Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Monday, 28 September 2020
Committee proceedings
House of Commons
Monday, 28 September 2020
Committee proceedings
House of Commons
Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Tuesday, 10 November 2020
Parliamentary proceedings
House of Lords
Tuesday, 10 November 2020
Parliamentary proceedings
House of Lords
Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Tuesday, 17 November 2020
Parliamentary proceedings
House of Lords
Tuesday, 17 November 2020
Parliamentary proceedings
House of Lords
Contains explanatory memorandum
YesSubjects
Legislation
European Union (Withdrawal) Act 2018Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020
Library location
Commons Library: UP 971 2019-21Librarians' tools
Timestamp
2024-05-13 11:17:08 +0100
URI
http://services.paperslaid.parliament.uk/papers/paper/43792
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://services.paperslaid.parliament.uk/papers/paper/43792
In Solr
https://search.parliament.uk/claw/solr/?id=http://services.paperslaid.parliament.uk/papers/paper/43792